BNTX vs ONC
BioNTech SE and BeOne Medicines AG, both Healthcare
BeOne Medicines AG is the larger company at $28B against $23B. Over the past year ONC returned +26% against +1.1% for BNTX. Ryufin's sector-relative Smart Score puts ONC ahead, 8/10 against 5/10.
| Figure | BNTX | ONC |
|---|---|---|
| Last close | $113 | $376 |
| Market cap | $23B | $28B |
| 1-year return | +1.1% | +26% |
| 5-year return | -66% | +15% |
| Ryufin Smart Scoresector-relative, 1–10 | 5/10 | 8/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
BioNTech SE
BeOne Medicines AG
Open these two in the interactive comparison to add more names, change the period or read the correlation.